Clinical Trial Update: Toripalimab Combined With S1 and Albumin Paclitaxel in Patients With Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab in combination with S1 and albumin-bound paclitaxel in advanced biliary tract cancer is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Albumin-bound paclitaxel (nab-paclitaxel)
• S1 (tegafur/gimeracil/oteracil)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Dai, Guanghai | Conditions: Advanced Biliary Tract Cancer | Phase 2 | Status: UNKNOWN